# Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis

> **NCT03943576** · PHASE1,PHASE2 · COMPLETED · sponsor: **Gwo Xi Stem Cell Applied Technology Co., Ltd.** · enrollment: 25 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** GXCPC1
- **DEVICE:** HA

## Key facts

- **NCT ID:** NCT03943576
- **Lead sponsor:** Gwo Xi Stem Cell Applied Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-01
- **Primary completion:** 2022-04-27
- **Final completion:** 2023-03-22
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03943576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03943576, "Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03943576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*